Bibliografia UJ CM

1/1
John W. Eikelboom, Jacqueline Bosch, Stuart J. Connolly, Jessica Tyrwitt, Keith A.A. Fox, Eva Muehlhofer, Christoph Neumann, Christoph Tasto, Shrikant I. Bangdiwala, Rafael Diaz, Marco Alings, Gilles R. Dagenais, Darryl P. Leong, Eva M. Lonn, Alvaro Avezum, Leopoldo S. Piegas, Petr Widimsky, Alexander N. Parkhomenko, Deepak L. Bhatt, Kelley R.H. Branch, Jeffrey L. Probstfield, Patricio Lopez-Jaramillo, Lars Ryden, Nana Pogosova, Katalin Keltai, Matyas Keltai, Georg Ertl, Stefan Stoerk, Antonio L. Dans, Fernando Lanas, Yan Liang, Jun Zhu, Christian Torp-Pedersen, Aldo P. Maggioni, Patrick J. Commerford, Tomasz J. Guzik, Thomas Vanassche, Peter Verhamme, Martin O'Donnell, Andrew M. Tonkin, John D. Varigos, Dragos Vinereanu, Camillo Felix, Jae-Hyung Kim, Khairul S. Ibrahim, Basil S. Lewis, Kaj P. Metsarinne, Victor Aboyans, Phillippe Gabriel Steg, Masatsugu Hori, Ajay Kakkar, Sonia S. Anand, Andre Lamy, Mukul Sharma, Salim Yusuf.
Long-term treatment with the combination of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease : outcomes during the open label extension of the COMPASS trial.
European Heart Journal. Cardiovascular Pharmacotherapy
2022 : Vol. 8, nr 8, s. 786-795, il., bibliogr. 12 poz.
Autor korespondencyjny: John W. Eikelboom.
Online First 2022-04-06
p-ISSN: 2055-6837
e-ISSN: 2055-6845
AZ
ORG
AIF
IF: 7.100
Adres url:
Streszczenie w PubMed:
Wyświetl ponownie stosując format: